With adoption of the IADPSG method, the rates of GDM increased from 9.2% to 23.5% (p<0.001). The rates of primary cesarean were higher with the adoption of the IADPSG criteria (22.2% vs 19.4%, p¼0.001) and the incidence of shoulder dystocia appeared slightly higher (1.1% vs 0.8%, p¼0.07). The rate of preeclampsia improved with the adoption of the 1-step method (10.9% vs 8.2%, p<0.001). The rates of macrosomia and NICU admission did not change significantly. Controlling for maternal age, BMI, race/ethnicity, chronic hypertension, and parity, the odds of a diagnosis of GDM increased 3-fold (aOR 3.2, 95% CI 2.8-3.6) with 1-step testing -the odds of a shouder dystocia increased (aOR 1.6, 95% CI 1.01 e 2.4) while the odds of preeclampsia decreased (aOR 0.65, 95% CI 0.56 e 0.75). CONCLUSION: While the rates of GDM more than doubled with the adoption of the IADPSG, the rates of primary c-section and shoulder dystocia did not decrease. The incidence of preeclampsia did improve, and more research is needed to determine whether an increase in aspirin prophylaxis may have contributed to this. Other maternal and neonatal outcomes were not statistically different. Data regarding clinical outcomes is important to consider when deciding whether to adopt the IADPSG criteria.
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The association between one abnormal value on oral glucose tolerance test and neonatal diabetic markers Ohad Gluck, Hadas Ganer-Herman, Nataly Fainstein, Neri Katz, Julio Wainstein, Jacob Bar, Michal Kovo the Edith Wolfson Medical Center, holon, israel, Israel OBJECTIVE: Infants who are large for gestational age (LGA) are more likely than other infants to be obese in childhood, adolescence and early adulthood, and are inherently at a higher risk of cardiovascular and metabolic complications in adulthood. We aimed to investigate the association between pregnancies with one abnormal value (OAV) in the oral glucose tolerance test (OGTT) to neonatal skinfold thickness and umbilical cord C-peptide. STUDY DESIGN: This was a prospective controlled trial performed from January 2016 -May 2018. Included were women with OAV in the OGTT performed between 24-28 weeks of gestation, who delivered at the Edith Wolfson Medical Center. The control group included normoglycemic women, who delivered during the same time period. The following 'diabetic' variables were measured: maternal HbA1C and blood glucose level (on admission), umbilical cord (UC) C-peptide concentration, and neonatal skinfold thickness at 3 sites. Maternal and obstetric characteristics, and the 'diabetic variables, were compared between the OAV group and the control group.
LGA was defined as birthweight (BW) >90 th % and macrosomia was defined as BW>4000 gram.
RESULTS:
As compared to the control group (n¼56), the OAV group (n¼84) was older, 33.4AE5 years vs. 32.5AE7 years p¼0.002, had lower GA at delivery (p¼0.01), increased rate of macrosomia (<0.001) and LGA (p¼0.003). Regarding the diabetic variables, as compared to the controls, the OAV group had increased concentration of UC Cpeptide (1.7AE1.6 vs. 1.3AE1.1 units, p¼0.007) and increased maternal HbA1C (5.3AE0.4 vs. 5.1AE0.3 units, p¼0.01). Neonatal skinfold thickness measurements did not differ between the groups. By logistic regression analysis after controlling for confounders (birthweight, GA at delivery, and maternal body mass index), LGA was independently associated with the presence of OAV group: aOR 4.7, 95%CI 1.48-14.8, p¼0.008. CONCLUSION: One pathological value on OGTT is associated with increased level of UC C-peptide and increased maternal HbA1C.
LGA is independently associated with OAV. These findings indicate the continuum of risk for fetal adiposity that is associated with increasing maternal glucose intolerance in pregnancy.
Poster Session II OBJECTIVE: To assess machine learning and neural network model ability to predict adverse neonatal outcome in pregnancies complicated by gestational diabetes STUDY DESIGN: Machine learning was used to create pregnancy complication prediction model in diabetic women. Our model was coded using Python3.6 with Keras framework based on Google's TensorFlow. The model was implemented using a 4-layers fully-connected neural network: data were fed after batch normalization; another layer of dropout was applied to prevent the model from memorizing the training samples and overfitting the data.
Data were retrieved from the medical records of women diagnosed with gestational diabetes mellitus, who delivered in our medical center (2012) (2013) (2014) (2015) (2016) .
The following baseline characteristics were included: maternal age, body mass index, parity, gravity, oral glucose test results, diabetes treatment and glycemic control. We defined a composite neonatal adverse outcome including any of the following: large for gestational age neonate, shoulder dystocia, umbilical vein pH< 7.2, neonatal intensive care unit admission, respiratory distress syndrome, hyperbilirubinemia and polycythemia.
For the machine training phase 70% of the cohort was randomly selected, each sample included baseline parameters and the composite outcome. We have then used the rest of the samples to evaluate our model's accuracy. The baseline parameters were fed into the trained model and the predicted outcome was compared to the actual outcome RESULTS: 452 women with gestational diabetes mellitus were included. The incidence of composite neonatal adverse outcome was 40%. On the randomly picked samples used to evaluate our model, we demonstrated an accuracy rate of 91% in predicting adverse outcome CONCLUSION: A state-of-the-art machine learning algorithm presented promising ability to predict adverse neonatal outcome among women with gestational diabetes mellitus. The algorithm provides an opportunity to identify at-risk patients who may benefit from early fetal monitoring and intervention OBJECTIVE: Women with type 1 and 2 diabetes mellitus (DM) have increased risk of adverse perinatal outcomes, including carrying a fetus with congenital malformation, intrauterine fetal demise, intrauterine growth restriction, macrosomia, and postnatal metabolic disturbances. Early glycemic control in pregnancy is crucial for decreasing adverse outcomes. However, it is unclear whether preconception hyperglycemia also contributes to adverse perinatal outcomes in diabetes. We examined preconception versus intrauterine effects of hyperglycemia on perinatal outcomes using a mouse model of reciprocal embryo transfer, in which embryos produced with oocytes from diabetic (DMOD) or non-diabetic (COD) oocyte donors are transferred to diabetic (DMS) or nondiabetic (CS) surrogate mothers. STUDY DESIGN: Diabetes was induced by intraperitoneal injection of streptozotocin 200mg/kg into 5 weeks old CD-1 mice. Upon reaching sexual maturity diabetic and control females were used as oocyte donors for in vitro fertilization (IVF) and as surrogate mothers for embryo transfer. Caesarian section was performed at term. One-way ANOVA was used to compare embryo ability to develop (implantation, fetal and abortion rates), fetal and placental weights, and incidence of congenital anomalies. RESULTS: The diabetic and non-diabetic surrogate mothers had similar ability to carry pregnancy, evidenced as rate of live fetuses (%, DMOD-DMS: 49 AE 7; COD-DMS: 51AE 9; DMOD-CS: 66 AE 6; COD-CS: 60 AE 8; P¼0.43). Implantation and abortion rates also did not differ among the four groups (P¼0.81 and P¼0.14). Fetal weights were significantly decreased in offspring from diabetic surrogate mothers, (g, DMOD-DMS: 0.9 AE 0.03; COD-DMS: 0.77AE 0.04; DMOD-CS: 1.37 AE 0.02; COD-CS: 1.35 AE 0.02; P¼0.0012) while placental weights were similar (P¼0.43). Fetuses with major congenital anomalies (anencephaly, myelomenigocele, abdominal wall defect) were observed only with diabetic surrogate mothers (%, DMOD-DMS: 15 AE 6; COD-DMS: 35 AE 15; P¼0.003). CONCLUSION: Diabetic status does not interfere with ability to carry pregnancy. However, adverse perinatal outcomes result when pregnancy is carried by diabetic surrogate mothers regardless whether oocytes are from diabetic or non-diabetic donor. This suggests that pregnancy environment is causative of adverse perinatal outcomes associated with diabetes, which underlines the importance of glycemic control in pregnancy.
